Cancer Treatments

My Personal Therapeutics and Pentavere receive EUREKA Artificial Intelligence/Quantum Therapeutics Funding to support the development of My Personal Therapeutics’ digital therapeutics for Lung Cancer

Study shows vastly improved turnaround time to get results from the lab to the oncologist using the newest technology in the cancer testing space

Researchers have discovered how to turn off a gene that causes an aggressive form of breast cancer to rapidly grow

Dana-Farber Cancer Institute scientists have identified several features of kidney cancer tumors that influence their response to immune checkpoint inhibitor drugs

Previous studies have shown that not all patients with metastatic breast cancer benefit from immunotherapy

Next-generation gene sequencing finds mutations in patients resistant to PSMA-targeting therapy

Researchers have identified important drivers that enable tumors to change their behavior and evade anticancer therapies

The largest report of commercial CAR T therapy for lymphoma demonstrates its effectiveness even in patients that would not have been eligible for clinical trials

Researchers have now managed to eliminate leukemic and hematopoietic stem cells more selectively in an animal model, sparing healthy cells and tissues

Understanding how donor white blood cells remain active against recipient cells can pave the way for novel treatment strategies in graft-versus-host disease